Report Summary
Eternity Insights has published a new study on Global InVitro Fertilization (IVF) Market focusing on key segments as by Type (Intrauterine Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), Drug and Hormone Therapies, Other), by Application (Male Infertility, Female Infertility, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global InVitro Fertilization (IVF) Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
InVitro Fertilization (IVF) Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global InVitro Fertilization (IVF) Market Size, 2018-2028 (USD Million)
To learn more about this report
Global InVitro Fertilization (IVF) Market Segmentation:
InVitro Fertilization (IVF) Market, By Type
- Intrauterine Insemination (IUI)
- Intra Cytoplasmic Sperm Injection (ICSI)
- Drug and Hormone Therapies
- Other
InVitro Fertilization (IVF) Market, By Application
- Male Infertility
- Female Infertility
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global InVitro Fertilization (IVF) market in terms of demand generation. The InVitro Fertilization (IVF) market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for InVitro Fertilization (IVF) market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global InVitro Fertilization (IVF) Market Taxonomy:
To learn more about this report
Global InVitro Fertilization (IVF) Market Competitive Landscape
The global InVitro Fertilization (IVF) market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Vitrolife AB
- Merck Serono
- Ferring Pharmaceuticals
- Irvine Scientific
- GeneaBiomedx
- Cooper Surgical
- Origio
- Genea
- Halotech Dna
- Auxilium Pharmaceuticals
- Auxogyn
- Ovascience
- Andrology Solutions
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Intrauterine Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), Drug and Hormone Therapies, Other |
| By Application Outlook |
Male Infertility, Female Infertility, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Vitrolife AB, Merck Serono, Ferring Pharmaceuticals, Irvine Scientific, GeneaBiomedx, Cooper Surgical, Origio, Genea, Halotech Dna, Auxilium Pharmaceuticals, Auxogyn, Ovascience, Andrology Solutions |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 InVitro Fertilization (IVF) Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global InVitro Fertilization (IVF) Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China InVitro Fertilization (IVF) Market Performance
2.3 USA InVitro Fertilization (IVF) Market Performance
2.4 Europe InVitro Fertilization (IVF) Market Performance
2.5 Japan InVitro Fertilization (IVF) Market Performance
2.6 Korea InVitro Fertilization (IVF) Market Performance
2.7 India InVitro Fertilization (IVF) Market Performance
2.8 Southeast Asia InVitro Fertilization (IVF) Market Performance
2.9 South America InVitro Fertilization (IVF) Market Performance
3 Global InVitro Fertilization (IVF) Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China InVitro Fertilization (IVF) Market Performance (Volume)
3.3 USA InVitro Fertilization (IVF) Market Performance (Volume)
3.4 Europe InVitro Fertilization (IVF) Market Performance (Volume)
3.5 Japan InVitro Fertilization (IVF) Market Performance (Volume)
3.6 Korea InVitro Fertilization (IVF) Market Performance (Volume)
3.7 India InVitro Fertilization (IVF) Market Performance (Volume)
3.8 Southeast Asia InVitro Fertilization (IVF) Market Performance (Volume)
3.9 South America InVitro Fertilization (IVF) Market Performance (Volume)
4 Competitive Analysis
4.1 Vitrolife AB
4.1.1 Vitrolife AB Profiles
4.1.2 Vitrolife AB Product Information
4.1.3 Vitrolife AB InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.1.4 Vitrolife AB InVitro Fertilization (IVF) Business Performance
4.1.5 SWOT Analysis
4.2 Merck Serono
4.2.1 Merck Serono Profiles
4.2.2 Merck Serono Product Information
4.2.3 Merck Serono InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.2.4 Merck Serono InVitro Fertilization (IVF) Business Performance
4.2.5 SWOT Analysis
4.3 Ferring Pharmaceuticals
4.3.1 Ferring Pharmaceuticals Profiles
4.3.2 Ferring Pharmaceuticals Product Information
4.3.3 Ferring Pharmaceuticals InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.3.4 Ferring Pharmaceuticals InVitro Fertilization (IVF) Business Performance
4.3.5 SWOT Analysis
4.4 Irvine Scientific
4.4.1 Irvine Scientific Profiles
4.4.2 Irvine Scientific Product Information
4.4.3 Irvine Scientific InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.4.4 Irvine Scientific InVitro Fertilization (IVF) Business Performance
4.4.5 SWOT Analysis
4.5 GeneaBiomedx
4.5.1 GeneaBiomedx Profiles
4.5.2 GeneaBiomedx Product Information
4.5.3 GeneaBiomedx InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.5.4 GeneaBiomedx InVitro Fertilization (IVF) Business Performance
4.5.5 SWOT Analysis
4.6 Cooper Surgical
4.6.1 Cooper Surgical Profiles
4.6.2 Cooper Surgical Product Information
4.6.3 Cooper Surgical InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.6.4 Cooper Surgical InVitro Fertilization (IVF) Business Performance
4.6.5 SWOT Analysis
4.7 Origio
4.7.1 Origio Profiles
4.7.2 Origio Product Information
4.7.3 Origio InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.7.4 Origio InVitro Fertilization (IVF) Business Performance
4.7.5 SWOT Analysis
4.8 Genea
4.8.1 Genea Profiles
4.8.2 Genea Product Information
4.8.3 Genea InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.8.4 Genea InVitro Fertilization (IVF) Business Performance
4.8.5 SWOT Analysis
4.9 Halotech Dna
4.9.1 Halotech Dna Profiles
4.9.2 Halotech Dna Product Information
4.9.3 Halotech Dna InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.9.4 Halotech Dna InVitro Fertilization (IVF) Business Performance
4.9.5 SWOT Analysis
4.10 Auxilium Pharmaceuticals
4.10.1 Auxilium Pharmaceuticals Profiles
4.10.2 Auxilium Pharmaceuticals Product Information
4.10.3 Auxilium Pharmaceuticals InVitro Fertilization (IVF) Production, Revenue, Price and Gross Margin
4.10.4 Auxilium Pharmaceuticals InVitro Fertilization (IVF) Business Performance
4.10.5 SWOT Analysis
4.11 Auxogyn
4.12 Ovascience
4.13 Andrology Solutions
5 Competitive Landscape
5.1 Global InVitro Fertilization (IVF) Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global InVitro Fertilization (IVF) Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global InVitro Fertilization (IVF) Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global InVitro Fertilization (IVF) Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global InVitro Fertilization (IVF) Market Assessment by Regions
6.1 Global InVitro Fertilization (IVF) Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global InVitro Fertilization (IVF) Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global InVitro Fertilization (IVF) Price (USD/Unit) by Regions (2014-2020)
6.4 Global InVitro Fertilization (IVF) Gross Margin by Regions (2014-2020)
7 InVitro Fertilization (IVF) Regional Analysis
7.1 China InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.2 USA InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.3 Europe InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.4 Japan InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.5 Korea InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.6 India InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
7.8 South America InVitro Fertilization (IVF) Production, Revenue and Growth Rate (2014-2020)
8 Global InVitro Fertilization (IVF) Consumption Assessment
8.1 Global InVitro Fertilization (IVF) Consumption and Market Share by Regions (2014-2020)
8.2 Global InVitro Fertilization (IVF) Consumption Value and Market Share by Regions (2014-2020)
8.3 Global InVitro Fertilization (IVF) Average Price (USD/Unit) by Regions (2014-2020)
9 Global InVitro Fertilization (IVF) Sales Assessment by Regions
9.1 Global InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.2 China InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.3 USA InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.4 Europe InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.5 Japan InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.6 Korea InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.7 India InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.8 Southeast Asia InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
9.9 South America InVitro Fertilization (IVF) Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global InVitro Fertilization (IVF) Production and Revenue by Regions 2020-2026
12.1.2 China InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.3 USA InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.7 India InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.1.9 South America InVitro Fertilization (IVF) Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global InVitro Fertilization (IVF) Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.3 China InVitro Fertilization (IVF) Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.5 Europe InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.6 Japan InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.7 Korea InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.8 India InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.2.10 South America InVitro Fertilization (IVF) Sales and Sales Value Forecast 2020-2026
12.3 Global InVitro Fertilization (IVF) Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 Intrauterine Insemination (IUI)
12.3.3 Intra Cytoplasmic Sperm Injection (ICSI)
12.3.4 Drug and Hormone Therapies
12.3.5 Other
12.4 Global InVitro Fertilization (IVF) Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 Male Infertility
12.4.3 Female Infertility
12.5 Global InVitro Fertilization (IVF) Price and Gross Margin Forecast
13.5.1 Global InVitro Fertilization (IVF) Averages Price Development Trend Forecast 2020-2026
13.5.2 Global InVitro Fertilization (IVF) Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
